Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Passive administration of neutralizing antibodies (Abs) is an attractive strategy for the control of gastrointestinal infections. However, an unanswered practical concern is the need to assure the stability of sufficient amounts of orally administered neutralizing Abs against intestinal pathogens (e...
Guardat en:
Autors principals: | Yoshikazu Yuki (Autor), Fanglei Zuo (Autor), Shiho Kurokawa (Autor), Yohei Uchida (Autor), Shintaro Sato (Autor), Naomi Sakon (Autor), Lennart Hammarström (Autor), Hiroshi Kiyono (Autor), Harold Marcotte (Autor) |
---|---|
Format: | Llibre |
Publicat: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Nanobody
Publicat: (2021) -
Norovírus em alimentos | Norovirus in foods
per: Isabelle da Silva Luz, et al.
Publicat: (2017) -
OP 6.5 - 00164 Nanobody-engineered AAV vectors for CD4-targeted gene therapy
per: U. Lange, et al.
Publicat: (2022) -
Norovirus
Publicat: (2021) -
Genetic recombination and genotype diversity of norovirus GI in children with acute gastroenteritis in Thailand, 2015-2021
per: Pattara Khamrin, et al.
Publicat: (2024)